Overview of the State Medicines Control Agency (VVKT) and Medical Product Regulation in Lithuania

State Medicines Control Agency of Lithuania (VVKT) Overview

The State Medicines Control Agency (VVKT) (Valstybinė vaistų kontrolės tarnyba) under the Ministry of Health of the Republic of Lithuania is the primary national competent authority responsible for protecting public health through the evaluation, authorization, and supervision of medicinal products for human use. In alignment with the broader European Union regulatory environment, it coordinates closely with regional bodies to monitor health technologies, clinical investigations, and market vigilance.

Core Roles and Competencies

While historically the State Health Care Accreditation Agency (VASPVT) held specific mandates for standard medical device registries, VVKT serves a critical, expanding role in the national and European lifecycle of medical technologies:

• Scientific Advice and Innovation: VVKT provides comprehensive scientific and regulatory advice to manufacturers, researchers, and biotech innovators. This is especially vital for advanced therapy medicinal products (ATMPs), borderlines between medicines and medical devices, and innovative drug-device combination products under the EU Medical Device Regulation (MDR).
• Clinical Trials Oversight: The agency evaluates and authorizes clinical trials conducted within Lithuania, working alongside the Lithuanian Bioethics Committee to ensure the safety, ethical compliance, and data integrity of clinical evaluations.
• Market Supervision and Licensing: VVKT supervises manufacturing and wholesale distribution authorization holders, enforcing strict compliance with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) standards.
• Pharmacovigilance and Vigilance Networks: The agency operates a robust monitoring network to constantly track the safety profile of authorized therapies, accepting adverse reaction reports from both healthcare specialists and patients, and coordinating necessary market recalls or restrictions.

European Alignment and International Cooperation

As an active member of the European Medicines Agency (EMA) network and EU working groups, VVKT plays a prominent international role:

• Decentralized and Mutual Recognition Procedures: VVKT acts as a Reference Member State (RMS) or Concerned Member State (CMS) for European marketing authorizations.
• Global Capacity Building: Demonstrating its regulatory maturity, VVKT acts as the lead partner in major EU Twinning projects (e.g., assisting Ukraine in establishing its independent state control authority for medicines and medical devices), transferring European best practices in market supervision and institutional development.